cicletanine has been researched along with Malignant Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autret, A; Bakri, F; Droy-Lefaix, MT; Guillemain, J; Ruchoux, MM; Ruchoux, P | 1 |
| Bakri, F; Berthet, P; Bosquet, D; Droy-Lefaix, MT; Lhuintre, Y; Ruchoux, MM | 1 |
2 other study(ies) available for cicletanine and Malignant Hypertension
| Article | Year |
|---|---|
Cicletanine and hypertensive retinopathy.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diuretics; Hypertension, Malignant; Pigment Epithelium of Eye; Pyridines; Random Allocation; Rats; Rats, Inbred SHR; Retina; Retinal Diseases; Retinal Ganglion Cells | 1990 |
[Malignant hypertensive retinopathy in spontaneously hypertensive stroke-prone rats. Effect of treatment with cicletanine].
Topics: Animals; Diuretics; Hypertension, Malignant; Microscopy, Electron; Pyridines; Random Allocation; Rats; Rats, Inbred SHR; Retinal Diseases | 1989 |